Related Experiment Videos
Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats
C R Scanzello1, G Hatzidimitriou, A L Martello
1Department of Neurology, Francis Scott Key Medical Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract:
(+/-)-3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3H]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82% depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evidence in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
MDMA (3,4-Methylenedioxymethamphetamine) damages serotonin neurons in rats, but recovery is observed over time. However, some rats show persistent deficits, indicating variable long-term effects.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- 3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug known to cause damage to serotonin (5-HT) neurons.
- While MDMA-induced neurotoxicity appears permanent in monkeys, studies in rats suggest potential for neuronal recovery.
Purpose of the Study:
- To investigate the long-term fate of serotonin neurons in rats following MDMA administration.
- To compare the neurotoxic and recovery patterns of MDMA in rats with findings in monkeys.
Main Methods:
- Rats received MDMA (10 mg/kg) every 2 hours for a total dose of 40 mg/kg.
- Neurochemical analyses of regional brain serotonin, 5-hydroxyindoleacetic acid, and [3H]paroxetine-labeled 5-HT uptake sites were performed at 2, 8, 16, 32, and 52 weeks post-treatment.
- Morphologic immunocytochemical studies were conducted to corroborate neurochemical findings.
Main Results:
- MDMA treatment caused significant reductions (42-82%) in 5-HT neuronal markers two weeks post-administration.
- Evidence of recovery was observed by 16 weeks in some brain regions, with near-complete recovery in most regions by 32 weeks.
- One year after MDMA, most rats showed recovery, but a subset exhibited severe, enduring serotonergic deficits in multiple brain areas.
Conclusions:
- Serotonin neurons in rats demonstrate a capacity for recovery after MDMA exposure.
- Individual variability exists, with some rats experiencing long-term, severe serotonergic deficits despite overall group recovery.
- Findings highlight the complex and potentially variable long-term neurotoxic effects of MDMA on the serotonergic system.